Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Grown Rogue International Inc. publishes a filing, an earnings call transcript or a press release.
Get GRUSF alertsRyan Kee is recorded as CFO at Grown Rogue International Inc. (GRUSF). The proxy statement of Grown Rogue International Inc. reports total compensation of $60,353 for Ryan Kee in fiscal 2024, including a base salary of $14,402. Disclosed compensation is on record for 2 fiscal years. Ryan Kee has spoken on 1 earnings call across 1 company, most recently for Grown Rogue International Inc. on August 4, 2026. Grown Rogue International Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Grown Rogue International Inc. includes J. Obie Strickler (CEO) and Andrew Marchington (CFO).
“I just wanted to take a minute to talk about capital allocation and how we keep our discipline with business development and reflect on the time and energy that I've continued to spend on evaluating distress in the industry.”
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Grown Rogue International Inc. (GRUSF) | Former Chief Financial Officer and current Director | — | — |
| 2024 | Grown Rogue International Inc. (GRUSF) | Former Chief Financial Officer and current Director | $14,402 | $60,353 |